Companies: 10,795·Total market cap: $144.5T
Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated

PRLDNASDAQHealthcare● Active
$3.99
+$0.15(+3.91%)
Market Cap$227161780
P/E Ratio
52W High$5.54
52W Low$0.75
Overview

Prelude Therapeutics Incorporated(PRLD)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRLD · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$103.21M$133.61M$232.94M$201.73M$291.23M
Net Receivables$0.00M$0.00M$0.00M$0.00M$0.00M
Inventory$0.00M$0.00M$0.00M$0.00M$0.00M
Total Current Assets$105.69M$135.90M$235.59M$204.38M$295.12M
PP&E Net$32.28M$35.47M$37.74M$6.70M$5.64M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M$0.00M
Total Assets$141.31M$175.51M$277.67M$220.50M$305.10M
Liabilities
Short-Term Debt$2.74M$0.00M$0.00M$0.00M$0.00M
Accounts Payable$3.98M$7.73M$4.58M$6.78M$7.84M
Total Current Liabilities$52.99M$25.64M$21.83M$21.70M$19.20M
Long-Term Debt$15.04M$0.00M$0.00M$0.00M$0.00M
Total Liabilities$72.68M$44.06M$40.58M$25.06M$19.20M
Stockholders Equity
Retained Earnings($683.06M)($583.56M)($456.39M)($334.56M)($219.12M)
Total Stockholders Equity$68.64M$131.46M$237.09M$195.44M$285.90M
Total Liab & Equity(computed)$141.31M$175.51M$277.67M$220.50M$305.10M
Debt Summary
Total Debt$17.79M$18.02M$16.89M$1.83M$1.74M
Net Debt($17.47M)$5.55M($8.40M)($28.77M)($30.09M)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Prelude Therapeutics Incorporated

关于Prelude Therapeutics Incorporated(PRLD)资产负债表

Prelude Therapeutics Incorporated总资产$0.14B,现金及短期投资$0.10B,总负债$0.07B,总债务$0.02B,股东权益$0.07B。

常见问题

PRLD · 4 问

Prelude Therapeutics Incorporated总债务$0.02B,净债务($0.02B)。

PRLD total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10